Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

963
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
963
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

1.5K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.5K
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

620
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
620
Other Pulmonary Disorders01:17

Other Pulmonary Disorders

1.7K
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
1.7K
Overview of Pulmonary Circulation01:19

Overview of Pulmonary Circulation

3.1K
The pulmonary circulation is a vital system in our body that acts as a bridge between the respiratory and cardiovascular systems. It serves as a transport network for deoxygenated blood from the heart to the lungs and then returns oxygen-rich blood back to the heart.
The process begins with the right ventricle of the heart pumping deoxygenated blood into the pulmonary trunk. This large vessel extends about 5 centimeters before splitting into the left and right pulmonary arteries. These arteries...
3.1K
Factors Affecting Pulmonary Ventilation01:19

Factors Affecting Pulmonary Ventilation

3.2K
Besides the pressure difference between the external environment and the lungs, the airflow rate and ease of pulmonary ventilation are also influenced by three other factors: surface tension of the fluid in the alveoli, compliance of the lungs, and airway resistance.
Alveolar Surface Tension
The alveolar fluid lines the luminal surface of the alveoli and exerts a force called surface tension. This force is caused by the polar water molecules in the liquid being more strongly attracted to each...
3.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Respiratory alterations in patients with amyotrophic lateral sclerosis.

Medicina clinica·2026
Same author

Saline lavage alone prolongs drainage compared with intrapleural enzyme therapy in pleural infection: the SCOPE randomised controlled trial.

The European respiratory journal·2026
Same author

Paradigm shift in the diagnosis of tuberculous pleural effusion: impact of epidemiology.

Journal of thoracic disease·2026
Same author

Use of artificial humidification during non-invasive mechanical ventilation in patients with acute respiratory failure: a narrative review.

Journal of thoracic disease·2025
Same author

Analyzing pleural fluid attributes in SARS-CoV-2 infection: a systematic review.

Journal of thoracic disease·2025
Same author

Prognostic influence of cardiac comorbidities in chronic obstructive pulmonary disease.

Respiratory medicine·2025

Related Experiment Video

Updated: Feb 2, 2026

Murine Echocardiography of Left Atrium, Aorta, and Pulmonary Artery
08:17

Murine Echocardiography of Left Atrium, Aorta, and Pulmonary Artery

Published on: February 20, 2017

15.0K

Pulmonary vasculitis.

Ana Casal, Juan Díaz-Garel, Tara Pereiro

  • 1Interdisciplinary Research Group in Pneumology, Institute of Sanitary Research of Santiago de Compostela (IDIS), Santiago de Compostela, Spain.

Journal of Thoracic Disease
|November 13, 2018
PubMed
Summary
This summary is machine-generated.

Pulmonary vasculitis presents diagnostic challenges due to varied symptoms. Early identification of systemic vasculitis affecting lungs, skin, and kidneys is crucial for effective treatment and preventing severe complications.

Keywords:
Pulmonary vasculitisanti-basement membrane antibodiesantineutrophil cytoplasmic antibodies (ANCAs)diffuse alveolar hemorrhageeosinophilic granulomatosis with polyangiitis (EGP)granulomatosis with polyangiitismicroscopic polyangiitis (MPA)

More Related Videos

Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension
10:03

Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension

Published on: June 27, 2025

786
Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis
06:03

Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis

Published on: May 9, 2025

1.8K

Related Experiment Videos

Last Updated: Feb 2, 2026

Murine Echocardiography of Left Atrium, Aorta, and Pulmonary Artery
08:17

Murine Echocardiography of Left Atrium, Aorta, and Pulmonary Artery

Published on: February 20, 2017

15.0K
Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension
10:03

Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension

Published on: June 27, 2025

786
Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis
06:03

Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis

Published on: May 9, 2025

1.8K

Area of Science:

  • Rheumatology and Pulmonology
  • Internal Medicine

Background:

  • Systemic vasculitides commonly impact pulmonary vasculature, presenting diagnostic and therapeutic challenges.
  • Nonspecific signs and symptoms of pulmonary vasculitis necessitate a high index of suspicion for severe, rapidly progressive lung disease.

Purpose of the Study:

  • To highlight the diagnostic complexities and management strategies for pulmonary vasculitis.
  • To emphasize the importance of multi-organ assessment and early diagnosis in vasculitic diseases affecting the lungs.

Main Methods:

  • Review of clinical presentations and diagnostic approaches for pulmonary vasculitis.
  • Integration of findings from organ-specific examinations (skin, kidneys) and autoantibody testing.
  • Role of radiological studies in diagnosis.

Main Results:

  • Pulmonary involvement is frequent in small-vessel vasculitis, anti-glomerular basement membrane disease, and ANCA-associated vasculitis.
  • Diffuse alveolar hemorrhage and kidney damage are severe, life-threatening complications requiring prompt diagnosis.

Conclusions:

  • Early diagnosis and comprehensive management of systemic vasculitides affecting the lungs are critical.
  • Multidisciplinary collaboration and familiarity with novel therapies, including biologics and immunosuppressants, are essential for optimal patient outcomes.